Moderna Stock Future Price Prediction

MRNA
 Stock
  

USD 171.18  0.63  0.37%   

Moderna stock price prediction is an act of determining the future value of Moderna shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Moderna's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Moderna and does not consider all of the tangible or intangible factors available from Moderna's fundamental data. We analyze noise-free headlines and recent hype associated with Moderna, which may create opportunities for some arbitrage if properly timed.
Additionally, see Moderna Basic Forecasting Models to cross-verify your projections.
  
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Moderna based on different types of headlines from major news networks to social media. The Moderna stock price prediction module provides an analysis of price elasticity to changes in media outlook on Moderna over a specific investment horizon.
Quarterly Earnings Growth YOY
-0.19
EPS Estimate Next Quarter
7.14
EPS Estimate Current Year
27.78
EPS Estimate Next Year
8.66
Wall Street Target Price
221.4
EPS Estimate Current Quarter
4.55
Quarterly Revenue Growth YOY
0.091
Using Moderna hype-based prediction, you can estimate the value of Moderna from the perspective of Moderna response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Moderna using Moderna's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Moderna using crowd psychology based on the activity and movement of Moderna's stock price.
Moderna PPandE Turnover is projected to increase significantly based on the last few years of reporting. The past year's PPandE Turnover was at 24.02. The current year Accounts Payable Turnover is expected to grow to 124.42, whereas Long Term Debt to Equity is forecasted to decline to 0.0349.

Moderna Short Interest

A significant increase or decrease in Moderna's short interest from the previous month could be a good indicator of investor sentiment towards Moderna. Short interest can provide insight into the potential direction of Moderna stock and how bullish or bearish investors feel about the market overall. An investor who is long Moderna may also wish to track short interest. As short interest increases, investors should be becoming more worried about Moderna and may potentially protect profits, hedge Moderna with its derivative instruments, or be ready for some potential downside.
200 Day MA
185.99
Short Percent
0.0508
Short Ratio
3.3
Shares Short Prior Month
16.3 M
50 Day MA
155.47
Shares Short
14.7 M
Beta
1.6

Moderna Hype to Price Pattern

Investor biases related to Moderna's public news can be used to forecast risks associated with investment in Moderna. The trend in average sentiment can be used to explain how an investor holding Moderna can time the market purely based on public headlines and social activities around Moderna. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Moderna's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Moderna.

Moderna Implied Volatility

    
  55.51  
Moderna's implied volatility exposes the market's sentiment of Moderna stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Moderna's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Moderna stock will not fluctuate a lot when Moderna's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Moderna. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Moderna to buy its stock at a price that has no basis in reality. In that case, they are not buying Moderna because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Moderna after-hype prediction price

    
  $ 167.08  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Moderna contract

Based on the Rule 16, the options market is currently suggesting that Moderna will have an average daily up or down price movement of about 3.47% per day over the life of the 2022-08-19 option contract. With Moderna trading at $171.18, that is roughly $5.94. If you think that the market is fully incorporating Moderna's daily price movement you should consider acquiring Moderna options at the current volatility level of 55.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Moderna's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Moderna in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
154.06212.49216.73
Details
Naive
Forecast
LowNext ValueHigh
180.10184.34188.57
Details
13 Analysts
Consensus
LowTarget PriceHigh
86.00257.23506.00
Details
Earnings
Estimates (10)
LowProjected EPSHigh
22.2526.3228.11
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Moderna. Your research has to be compared to or analyzed against Moderna's peers to derive any actionable benefits. When done correctly, Moderna's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Moderna.

Moderna After-Hype Price Prediction Density Analysis

As far as predicting the price of Moderna at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Moderna or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Moderna, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Moderna Estimiated After-Hype Price Volatility

In the context of predicting Moderna's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Moderna's historical news coverage. Moderna's after-hype downside and upside margins for the prediction period are 162.84 and 171.32, respectively. We have considered Moderna's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 171.18
162.84
Downside
167.08
After-hype Price
171.32
Upside
Moderna is very steady asset. Analysis and calculation of next after-hype price of Moderna is based on 3 months time horizon.

Moderna Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Moderna is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Moderna backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Moderna, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.44  4.24   4.10    1.02  11 Events / Month0 Events / MonthIn about 11 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
171.18167.082.40 
45.49  

Moderna Hype Timeline

Moderna is now traded for 171.18. The entity has historical hype elasticity of -4.1 and average elasticity to hype of competition of -1.02. Moderna is estimated to decline in value after the next headline with price expected to drop to 167.08. The average volatility ofmedia hypeimpact on the company stock price is about 45.49%. The price decrease on the next newsis expected to be -2.4% whereas the daily expected return is now at 0.44%. The volatility of related hype on Moderna is about 182.76% with expected price after next announcement by competition of 170.16. About 64.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 16.69. Moderna had not issued any dividends in recent years. The entity had 1:10 split on the 3rd of August 2017. Given the investment horizon of 90 days the next estimatedpress releasewill be in about 11 days.
Additionally, see Moderna Basic Forecasting Models to cross-verify your projections.

Moderna Related Hype Analysis

Having access to credible news sources related to Moderna's direct competition is more important than ever and may enhance your ability to predict Moderna's future price movements. Getting to know how Moderna rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Moderna may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GOOGLAlphabet Cl A(2.32) 10 per month 2.22  0.0173  4.20 (3.92)  10.75 

Moderna Additional Predictive Modules

Most predictive techniques to examine Moderna price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Moderna using various technical indicators. When you analyze Moderna charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Moderna Predictive Indicators

The successful prediction of Moderna stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Moderna, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Moderna based on analysis of Moderna hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Moderna's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Moderna's related companies.
 2021 2022 (projected)
Calculated Tax Rate7.347.29
Long Term Debt to Equity0.04230.0349

Story Coverage note for Moderna

The number of cover stories for Moderna depends on current market conditions and Moderna's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Moderna is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Moderna's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Moderna Short Properties

Moderna's future price predictability will typically decrease when Moderna's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Moderna often depends not only on the future outlook of the potential Moderna's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Moderna's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out4.09%
Short Percent Of Float5.49%
Float Shares360.03M
Shares Short Prior Month14.76M
Average Daily Volume Last 10 Day5.22M
Average Daily Volume In Three Month5.2M
Date Short Interest15th of July 2022
Additionally, see Moderna Basic Forecasting Models to cross-verify your projections. Note that the Moderna information on this page should be used as a complementary analysis to other Moderna's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Moderna Stock analysis

When running Moderna price analysis, check to measure Moderna's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Moderna is operating at the current time. Most of Moderna's value examination focuses on studying past and present price action to predict the probability of Moderna's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Moderna's price. Additionally, you may evaluate how the addition of Moderna to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Is Moderna's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Moderna. If investors know Moderna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Moderna listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.19
Market Capitalization
67 B
Quarterly Revenue Growth YOY
0.091
Return On Assets
0.46
Return On Equity
1.14
The market value of Moderna is measured differently than its book value, which is the value of Moderna that is recorded on the company's balance sheet. Investors also form their own opinion of Moderna's value that differs from its market value or its book value, called intrinsic value, which is Moderna's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Moderna's market value can be influenced by many factors that don't directly affect Moderna's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Moderna's value and its price as these two are different measures arrived at by different means. Investors typically determine Moderna value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Moderna's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.